HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary resistance to gefitinib in a patient with lung adenocarcinoma harboring an EGFR exon 19 L747-A750>P mutation.

AuthorsQiang Wei, Jin Zhang, Dongsheng Chen, Si Li, Yuanhua Liu
JournalLung cancer (Amsterdam, Netherlands) (Lung Cancer) Vol. 148 Pg. 175-176 (10 2020) ISSN: 1872-8332 [Electronic] Ireland
PMID32883519 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • EGFR protein, human
  • ErbB Receptors
  • Gefitinib
Topics
  • Adenocarcinoma of Lung (drug therapy, genetics)
  • Antineoplastic Agents (therapeutic use)
  • ErbB Receptors (genetics)
  • Exons (genetics)
  • Gefitinib (therapeutic use)
  • Humans
  • Lung Neoplasms (drug therapy, genetics)
  • Mutation
  • Protein Kinase Inhibitors (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: